OncoSeek is 16th selected out of 500 proposals received for the Covid-19 research association project. The company envisions creating a novel in vitro platforms for Covid-19 research.
Hyderabad is putting extra effort to tackle the pandemic; the University of Hyderabad has been selected for funding of Covid-19 by the Biotechnology Industry Research Assistance Council (BIRAC).
The BIRAC, which comes under the Union Science and Technology Ministry’s Department of Biotechnology, is providing the funding support to OncoSeek Bio Pvt Ltd for developing an in vitro Lung Organoid model.
Talking about the OncoSeek project, it is a selected proposal out of 500 projects received for Covis-19 research. The founder CEO of OncoSeek, Dr. Suresh Poosala said that “Current animal models available for research on Covid-19 are either difficult to get into India or create them in time, to address the pandemic. The company envisages creating a novel in vitro platforms for Covid-19 research under the support.”
More News: Startup Unfold
The founder of OncoSeek stated that “Under this grant proposal, the company plans to use their novel platform to screen drugs, peptides, molecules, agents, compounds targeted against the host cell or virus. It plans to create this capability in the next 6 months. “With the help of talented faculty at the School of Life Sciences, the University of Hyderabad, and ASPIRE- BioNEST, they can address the challenges and bring out the science to understand and solve the Covid-19 puzzle.”
OncoSeek is a setup incubates since 2019, at ASPIRE-BioNEST at UoH, and working to develop in vivo or vitro platforms for specific syndrome for therapeutics viewing.
BioNEST is a life sciences incubator at the University of Hyderabad, which is set up with the support of the BIRAC. The project is controlled by the DBT, to offer a plug and play life science ecological unit of incubation.